All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”
ME10027

Biomedical investigation of optically pure silybin derivatives ? from ?soft? nutraceuticals to targeted anticancer drug.

Public support

  • Provider

    Ministry of Education, Youth and Sports

  • Programme

    KONTAKT

  • Call for proposals

    KONTAKT 8 (SMSM2010ME5)

  • Main participants

  • Contest type

    VS - Public tender

  • Contract ID

    2062/2011-320

Alternative language

  • Project name in Czech

    Biomedicínský výzkum opticky čistých derivátů silybinu - od potravinového doplňku k cílené protinádorové léčbě.

  • Annotation in Czech

    Bude připravena skupina derivátů a potenciálních metabolitů silybinu a isosilybinu. Bude stanovena protinádorová aktivita připravených derivátů. Úspěšné sloučeniny budou předmětem dalšího zkoumání s cílem získat protinádorová léčiva s nízkou toxicitou.

Scientific branches

  • R&D category

    ZV - Basic research

  • CEP classification - main branch

    CC - Organic chemistry

  • CEP - secondary branch

    CE - Biochemistry

  • CEP - another secondary branch

    FR - Pharmacology and apothecary chemistry

  • OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)

    10401 - Organic chemistry<br>10608 - Biochemistry and molecular biology<br>10609 - Biochemical research methods<br>30104 - Pharmacology and pharmacy

Completed project evaluation

  • Provider evaluation

    V - Vynikající výsledky projektu (s mezinárodním významem atd.)

  • Project results evaluation

    New preparatory method for preparation of optically pure isosilybins and silybin disulfates was developed.In vitro tests for anticancer activity of the new compounds were done in collaboration with the US partner. Silybin sulfates using recombinant sulfotransferase were prepared. Analytical methods for purity verification of the compounds designed for biological tests were developed and validated.

Solution timeline

  • Realization period - beginning

    May 1, 2010

  • Realization period - end

    Dec 31, 2012

  • Project status

    U - Finished project

  • Latest support payment

    Feb 16, 2012

Data delivery to CEP

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

  • Data delivery code

    CEP13-MSM-ME-U/01:1

  • Data delivery date

    Jun 28, 2013

Finance

  • Total approved costs

    1,800 thou. CZK

  • Public financial support

    1,800 thou. CZK

  • Other public sources

    0 thou. CZK

  • Non public and foreign sources

    0 thou. CZK